Oxford North UK innovation district officially opened
Charlie Blackie-Kelly | October 16, 2025 | News story | Research and Development | Oxford North, University of Oxford, innovation district
Oxford North, a new innovation district in Oxford, UK, with planning permission for around one million sq ft of newly built, state-of-the-art laboratory and office space, has officially been opened by Lord Hague of Richmond, chancellor of the University of Oxford.
The first phase of development, now complete, includes two purpose-built laboratory buildings with flexible unit sizes and a 33,000 sq ft four-storey workspace. Both facilities are expected to be available in December.
Oxford North will serve the wider science and technology ecosystem, offering facilities suitable for start-ups, university spin-outs, mid-sized businesses and larger companies. The site is forecast to contribute £150m annually to the economy, with its proximity to the University of Oxford expected to foster stronger collaboration between academia and industry.
Lord Hague of Richmond, Chancellor, University of Oxford, said: “Oxford is a unique hub with an exceptional 900-year history, and is synonymous with life-changing scientific and technological breakthroughs. The continued investment into next generation infrastructure and inclusive opportunities such as Oxford North means this an exciting time to be part of this city.”
Professor Lady Sue Black, Baroness Black of Strome President of St John’s College, commented: “This is a unique opportunity for Oxford North occupiers to engage with academia and business as part of Oxford’s thriving innovation ecosystem and vibrant spin-out culture.”
Related Content
Terumo to acquire Oxford spin-out OrganOx in $1.5b deal
Japanese medical technology company Terumo has announced it will acquire OrganOx, a University of Oxford, …
GRAIL and University of Oxford showcase first prospective study results for multi-cancer early detection test
US-based healthcare company GRAIL and the University of Oxford, UK, have announced encouraging first prospective …
AstraZeneca’s COVID-19 vaccine generates immune response in both old and young participants
AstraZeneca’s much-hyped COVID-19 vaccine candidate, AZD1222, currently in development in partnership with the University of …
